Related references
Note: Only part of the references are listed.Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Using coordination chemistry to design new medicines
Luca Ronconi et al.
COORDINATION CHEMISTRY REVIEWS (2007)
Targeting the mitochondrial cell death pathway with gold compounds
Peter J. Barnard et al.
COORDINATION CHEMISTRY REVIEWS (2007)
A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity
Damin Fan et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Encapsulation of platinum anticancer drugs by apoferritin
Zhen Yang et al.
CHEMICAL COMMUNICATIONS (2007)
Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro
Donatella Aldinucci et al.
ANTI-CANCER DRUGS (2007)
Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats
Xinning Wang et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
Vesna Milacic et al.
CANCER RESEARCH (2006)
Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands
Angela Casini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects
Pengfei Shi et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2006)
Anticancer cyclometalated [AuIII m(C∧N∧C)mL]n+ compounds:: Synthesis and cytotoxic properties
Carrie Ka-Lei Li et al.
CHEMISTRY-A EUROPEAN JOURNAL (2006)
Antitumor active monofunctional platinum(II) complexes: Synthesis, structural characterization and reactivity towards biomolecules
Xinliu Gao et al.
INORGANIC CHEMISTRY COMMUNICATIONS (2006)
A positively charged trinuclear 3N-chelated monofunctional platinum complex with high DNA affinity and potent cytotoxicity
Yongmei Zhao et al.
DALTON TRANSACTIONS (2006)
Gold(III) compounds of 1,4,7-triazacyclononane showing high cytotoxicity against A-549 and HCT-116 tumor cell lines
Pengfei Shi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Gold(III) dithiocarbamate derivatives for the treatment of cancer:: Solution chemistry, DNA binding, and hemolytic properties
L Ronconi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Proteomic characterization of the cytotoxic mechanism of gold(III) porphyrin 1a, a potential anticancer drug
Y Wang et al.
PROTEOMICS (2006)
Metal-based antitumour drugs in the post genomic era
PJ Dyson et al.
DALTON TRANSACTIONS (2006)
Polymer therapeutics: Concepts and applications
R Haag et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Platinum group antitumor chemistry: Design and development of new anticancer drugs complementary to cisplatin
AS Abu-Surrah et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity
S van Zutphen et al.
COORDINATION CHEMISTRY REVIEWS (2005)
Gold(III) porphyrin 1a induced apoptosis by mitochondrial death pathways related to reactive oxygen species
Y Wang et al.
CANCER RESEARCH (2005)
Mechanisms of cytotoxicity of selected organogold(III) compounds
M Coronnello et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by novel traditional Chinese medicine-platinum anti-cancer agents
KKW To et al.
ANTI-CANCER DRUGS (2005)
Disulfide bond cleavage induced by a platinum(II) methionine complex
HY Wei et al.
INORGANIC CHEMISTRY (2005)
A surprisingly stable macrochelate formed from the reaction of cis dinuclear platinum antitumor compounds with reduced glutathione
ME Oehlsen et al.
INORGANIC CHEMISTRY (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Gold dithiocarbamate derivatives as potential antineoplastic agents:: Design, spectroscopic properties, and in vitro antitumor activity
L Ronconi et al.
INORGANIC CHEMISTRY (2005)
Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes
L Giovagnini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Molecular recognition of metal complexes by DNA: A comparative study of the interactions of the parent complexes [PtCl(TERPY)]Cl and [AuCl(TERPY)]Cl-2 with double stranded DNA
L Messori et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2005)
Update of the preclinical situation of anticancer platinum complexes: Novel design strategies and innovative analytical approaches
M Galanski et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure
A Hegmans et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Crystal structure, DNA-binding ability and cytotoxic activity of platinum(II) 2,2′-dipyridylamine complexes
C Tu et al.
INORGANICA CHIMICA ACTA (2004)
Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin
KKW To et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Adapter protein for site-specific conjugation of payloads for targeted drug delivery
MV Backer et al.
BIOCONJUGATE CHEMISTRY (2004)
Fast displacement of S,N-chelated L-methionine in platinum(II) complexes by biological thiols
HY Wei et al.
INORGANIC CHEMISTRY COMMUNICATIONS (2004)
Cytotoxic activity of metal complexes of biogenic polyamines: Polynuclear platinum(II) chelates
LJ Teixeira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells
S Lacour et al.
CANCER RESEARCH (2004)
Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
MP Rigobello et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Platinum-intercalator conjugates: From DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation
H Baruah et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Novel polynuclear platinum adducts detected during the reactions of [Pt(Met-S,N)Cl2] with γ-glutathione and L-cysteine
Q Liu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Synthesis, structure, and biological activity of new azine-bridged dinuclear platinum(II) complexes - a new class of anticancer compounds
GV Kalayda et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2003)
Toward the design of novel polynuclear platinum antitumor complexes: A polydentate ligand system based on dipyridylamine and 1,3,5-trimethylenebenzene
C Tu et al.
INORGANIC CHEMISTRY (2003)
Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy
ME Oehlsen et al.
INORGANIC CHEMISTRY (2003)
Novel Au(III) complexes of aminoquinoline derivatives: crystal structure, DNA binding and cytotoxicity against melanoma and lung tumour cells
T Yang et al.
DALTON TRANSACTIONS (2003)
Platinum-based anticancer agents: Innovative design strategies and biological perspectives
YP Ho et al.
MEDICINAL RESEARCH REVIEWS (2003)
New metal complexes as potential therapeutics
CX Zhang et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Monofunctional platinum complexes showing potent cytotoxicity against human liver carcinoma cell line BEL-7402
JY Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis, characterization, cytotoxic activity, and cellular accumulation of dinuclear platinum complexes derived from N,N′-di-(2-aminoethyl)-1,3-diantino-2-propanol, aryl substituted N-benzyl-1,4-butanediamines, and N-benzyl-1,6-hexanediamines
ET Cesar et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Nucleotide excision repair from site-specifically platinum-modified nucleosomes
D Wang et al.
BIOCHEMISTRY (2003)
Multi-nuclear platinum complexes as anti-cancer drugs
NJ Wheate et al.
COORDINATION CHEMISTRY REVIEWS (2003)
Toxicity of platinum compounds
JT Hartmann et al.
EXPERT OPINION ON PHARMACOTHERAPY (2003)
New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA
J Reedijk
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds
R Paschke et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin
S Komeda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Biochemical modulation of cisplatin mechanisms of action:: Enhancement of antitumor activity and circumvention of drug resistance
MA Fuertes et al.
CHEMICAL REVIEWS (2003)
5-fluorouracil-cisplatin adducts with potential antitumor activity
XY Wang et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Reactions of gold(III) complexes with serum albumin
G Marcon et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Extending solid-phase methods in inorganic synthesis: the first dinuclear platinum complex synthesised via the solid phase
S van Zutphen et al.
CHEMICAL COMMUNICATIONS (2003)
Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells
CM Che et al.
CHEMICAL COMMUNICATIONS (2003)
DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464 - Conformation, recognition by high mobility group domain proteins, and nucleotide excision
J Kasparkova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cytotoxic acridinylthiourea and its platinum conjugate produce enzyme-mediated DNA strand breaks
JM Brow et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Synthesis and preliminary in vitro evaluation of polymeric dicarboxylato- and dihydroxylatoplatinum(II) chelates as antiproliferative agents
EW Neuse et al.
POLYMERS FOR ADVANCED TECHNOLOGIES (2002)
Mechanisms of cytotoxicity and antitumor activity of gold(I) phosphine complexes: the possible role of mitochondria
MJ McKeage et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates
H Baruah et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Molecular aspects of resistance to antitumor platinum drugs
V Brabec et al.
DRUG RESISTANCE UPDATES (2002)
Gold derivatives for the treatment of cancer
ERT Tiekink
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity
C Lottner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents
C Lottner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole
S Komeda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Gold(III) complexes with bipyridyl ligands: Solution chemistry, cytotoxicity, and DNA binding properties
G Marcon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Transcription-coupled and DNA damage dependent ubiquitination of RNA polymerase II in vitro
KB Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells
O Briz et al.
MOLECULAR PHARMACOLOGY (2002)
MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA
ZZ Zdraveski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity
KNJ Burger et al.
NATURE MEDICINE (2002)
Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance
T Okada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore
ET Martins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
A rare example of three abundant conformers in one retro model of the cisplatin-DNA d(GpG) intrastrand cross link. Unambiguous evidence that guanine O6 to carrier amine ligand hydrogen bonding is not important. Possible effect of the lippard base pair step adjacent to the lesion on carrier ligand hydrogen bonding in DNA adducts
ST Sullivan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Hydrolysis theory for cisplatin and its analogues based on density functional studies
Y Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Further studies on the site-specific protein modification by microbial transglutaminase
H Sato et al.
BIOCONJUGATE CHEMISTRY (2001)
Current and future potential roles of the platinum drugs in the treatment of ovarian cancer
MJ Piccart et al.
ANNALS OF ONCOLOGY (2001)
Design of macromolecular prodrug of cisplatin using dextran with branched galactose units as tarqetinq moieties to hepatoma cells
Y Ohya et al.
BIOMACROMOLECULES (2001)
Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2-terpyridine)platinum(II) complexes.: Possible implications for a novel antitumor strategy
K Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Estrogen-derived steroidal metal complexes: Agents for cellular delivery of metal centers to estrogen receptor-positive cells
A Jackson et al.
INORGANIC CHEMISTRY (2001)
Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464
J Zehnulova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety
YP Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Current status of trans-platinum compounds in cancer therapy
G Natile et al.
COORDINATION CHEMISTRY REVIEWS (2001)
cis-dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-arboxamides:: synthesis and action in resistant cell lines in vitro
RJ Holmes et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2001)
Different recognition of DNA modified by antitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53
J Kasparkova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis
L Orlandi et al.
EUROPEAN JOURNAL OF CANCER (2001)
Interactions of selected gold(III) complexes with calf thymus DNA
L Messori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Dinuclear alkyldiamine platinum antitumor compounds: A structure-activity relationship study
BAJ Jansen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
ESMS and NMR investigations on the interaction of the anticancer drug cisplatin and chemopreventive agent selenomethionine
Q Liu et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2001)
Crystal structure and solution chemistry of the cytotoxic complex 1,2-dichlolro(o-phenanthroline)gold(III) chloride
F Abbate et al.
INORGANICA CHIMICA ACTA (2000)
Effects of monofunctional platinum binding on the thermal stability and conformation of a self-complementary 22-mer
T Peleg-Shulman et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2000)
Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
SP Vyas et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Gold(III) complexes as potential antitumor agents: Solution chemistry and cytotoxic properties of some selected gold(III) compounds
L Messori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
New antitumor-active azole-bridged dinuclear platinum(II) complexes: Synthesis, characterization, crystal structures, and cytotoxic studies
S Komeda et al.
INORGANIC CHEMISTRY (2000)
DNA targeted platinum complexes:: synthesis, cytotoxicity and DNA interactions of cis-dichloroplatinum(II) complexes tethered to phenazine-1-carboxamides
LC Perrin et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2000)
Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA
MD Temple et al.
BIOCHEMISTRY (2000)
Cisplatin resistance and oncogene - a review
W Dempke et al.
ANTI-CANCER DRUGS (2000)
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu)
S Carotti et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
Key steps of the cis-platin-DNA interaction:: Density functional theory-based molecular dynamics simulations
P Carloni et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2000)
Synthesis, crystal structure, spectral properties and cytotoxic activity of platinum(II) complexes of 2-acetyl pyridine and pyridine-2-carbaldehyde N(4)-ethyl-thiosemicarbazones
D Kovala-Demertzi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2000)
Share Paper
